Simon, Christopher Insider Profile

Simon, Christopher, President & CEO, Director at Haemonetics, holds 296.45K shares in Haemonetics (Ticker: HAE).
Simon, Christopher

Simon, Christopher
Haemonetics (HAE)
President & CEO, Director

Not Ranked
Simon, Christopher has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

A breakdown of Simon, Christopher's holdings

Insider Roles

President & CEO, Director
Roles that Simon, Christopher holds in companies

Most Profitable Insider Trade

Rating:Informative Buy
Date:Aug 08, 2016 - Aug 08, 2017
The most profitable trade made by Simon, Christopher

Simon, Christopher's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Jun 30, 2023
President & CEO, Director
Uninformative Sell
Success Rate for HAE
1 out of 1 profitable transactions on HAE
Average Return for HAE
Average return per transaction on HAE
No. of Shares
Price per Share
Link to Report
Jun 30, 2023
Uninformative Sell
Jul 01, 2016
Uninformative Buy
Aug 08, 2016
Informative Buy
Jun 08, 2017
Uninformative Buy
Jun 13, 2018
Uninformative Buy
List of latest transactions for each holding click on a transaction to see Simon, Christopher's performance on stock

Simon, Christopher insider profile FAQ

What is the percentage of profitable transactions made by Simon, Christopher?
The percentage of profitable transactions made by Simon, Christopher is ―.
    What is the average return per transaction made by Simon, Christopher?
    The average return per transaction made by Simon, Christopher is ―.
      What stocks does Simon, Christopher hold?
      Simon, Christopher holds: HAE stocks.
        What was Simon, Christopher’s latest transaction?
        Simon, Christopher latest transaction was an Uninformative Sell of $9.98M.
          What was Simon, Christopher's most profitable transaction?
          Simon, Christopher’s most profitable transaction was an Informative Buy of HAE stock on August 8, 2016. The return on the trade was 21.40%.
            What is Simon, Christopher's role in Haemonetics?
            Simon, Christopher's role in Haemonetics is President & CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.